EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Extracellular vesicles as novel mediators of pathology in Anderson–Fabry disease

Anna Olena Kalmykova, Maria Lina Massimino iD, Monica Vettore, Giorgia Gugelmo iD, Gianni Carraro, Laura De Michieli iD, Gian Paolo Fadini iD, Alessandro Bertoli iD, Nicola Vitturi iD, Livia Lenzini iD

Clinical Science · 13.05.2026 · 140 (5) · 651-662

DOI: 10.1042/cs20250868 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 17.04.2026. Verfasst von Anna Olena Kalmykova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolic Diseases, Department of Medicine, Padova University Hospital, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Fabry Disease, Extracellular Vesicles. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: Università degli Studi di Padova (UNIPD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anderson–Fabry disease (AFD) is an X-linked lysosomal storage disorder caused by GLA mutations that reduce α-galactosidase A activity, leading to systemic accumulation of globotriaosylceramide (Gb3). Increasing evidence indicates that extracellular vesicles (EVs) contribute to pathogenic signal dissemination in lysosomal storage disorders. We hypothesized that EVs released from AFD-affected cells transfer toxic metabolites and molecular cues to recipient cells, thereby amplifying disease mechanisms. As a proof-of-concept study, urinary EVs were isolated from adults with AFD and healthy controls by ultracentrifugation and characterized by flow cytometry. Renal immortalized cells (HEK293) were treated with either healthy or AFD EVs to assess Gb3 accumulation, α-galactosidase A activity, and autophagic markers (Beclin-1, LC3 II/LC3-I ratio, and p62) at multiple time points. HEK293 cells exposed for 24 h to urinary EVs from 10 AFD patients showed Gb3 accumulation comparable to that observed in urinary epithelial cells from AFD subjects, along with increased α-galactosidase A activity relative to untreated and control-EV–treated cells. This was accompanied by impairment of autophagic flux as indicated by elevated LC3B-II/LC3-I ratios and accumulation of the autophagy substrate p62 after 72 h of exposure to AFD EVs. Autophagic inhibition was further supported by a significant reduction of Beclin-1 at 24–72 h in cells exposed to AFD EVs and increased Bcl-2 expression, a negative regulator of Beclin-1. These findings provide new insight into the potential involvement of EVs in AFD pathogenesis, suggesting that systemic manifestations may arise, at least in part, from EV-mediated transfer of pathogenic lipids and signaling molecules to recipient cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fabry DiseaseExtracellular VesiclesHumansHEK293 CellsTrihexosylceramidesalpha-GalactosidaseAutophagyAdultFemaleBeclin-1MaleMicrotubule-Associated ProteinsMiddle AgedBiomarkersSequestosome-1 Protein

Stichwörter der Autor:innen

Anderson Fabry DiseaseAutophagyExtracellular Vesicles

Substanzen

Trihexosylceramidesglobotriaosylceramidealpha-GalactosidaseBeclin-1Microtubule-Associated ProteinsBiomarkersBECN1 protein, humanSequestosome-1 ProteinMAP1LC3A protein, human

Autor:innen und Institutionen

  • Division of Metabolic Diseases, Department of Medicine, Padova University Hospital, University of Padova, Padova, Italy.
  • Neuroscience Institute, National Research Council (CNR), Padova, Italy.
  • Nephrology, Dialysis and Transplant Unit, Department of Medicine, Padova University Hospital, University of Padova, Italy.
  • Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padova, Padova, Italy.
  • Department of Biomedical Sciences, University of Padova, Padova, Italy.
  • Padova Neuroscience Center, University of Padova, Padova, Italy.

ORCID-Profile: Maria Lina Massimino, Giorgia Gugelmo, Laura De Michieli, Gian Paolo Fadini, Alessandro Bertoli, Nicola Vitturi, Livia Lenzini

Förderung

  • Università degli Studi di Padova (UNIPD)

Zitieren

APA

Kalmykova, A. O., Massimino, M. L., Vettore, M., Gugelmo, G., Carraro, G., De Michieli, L., Fadini, G. P., Bertoli, A., Vitturi, N., & Lenzini, L. (2026). Extracellular vesicles as novel mediators of pathology in Anderson–Fabry disease. Clinical Science, 140(5), 651-662. https://doi.org/10.1042/cs20250868

Vancouver

Kalmykova AO, Massimino ML, Vettore M, Gugelmo G, Carraro G, De Michieli L, et al. Extracellular vesicles as novel mediators of pathology in Anderson–Fabry disease. Clinical Science. 2026;140(5):651-662. doi:10.1042/cs20250868

BibTeX
@article{Kalmykova2026,
  author = {Kalmykova, Anna Olena and Massimino, Maria Lina and Vettore, Monica and Gugelmo, Giorgia and Carraro, Gianni and De Michieli, Laura and Fadini, Gian Paolo and Bertoli, Alessandro and Vitturi, Nicola and Lenzini, Livia},
  title = {Extracellular vesicles as novel mediators of pathology in Anderson–Fabry disease},
  journal = {Clinical Science},
  year = {2026},
  volume = {140},
  number = {5},
  pages = {651--662},
  doi = {10.1042/cs20250868}
}
Kostenlos starten →